Risk Stratification of Nonvalvular Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis - United States
doi 10.1177/1076029613500708
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Duration of Nonvalvular Atrial Fibrillation and Stroke.

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
1983English

Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Yearbook of Cardiology
2012English

Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation

JAMA network open
Medicine
2020English

Platelet Activation in Patients With Chronic Nonvalvular Atrial Fibrillation

International Heart Journal
MedicineCardiovascular MedicineCardiology
2006English

Cost-Effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation

Archives of Internal Medicine
1998English

PRescriptiOn PattERns of Oral Anticoagulants in Nonvalvular Atrial Fibrillation (PROPER Study)

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2015English

Novel Anticoagulants for Thromboembolic Complications Prevention in Nonvalvular Atrial Fibrillation

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Potential of Machine Learning Methods to Identify Patients With Nonvalvular Atrial Fibrillation

Future Cardiology
Molecular MedicineCardiovascular MedicineCardiology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy